Menlo Therapeutics Inc. (MNLO): Price and Financial Metrics

Menlo Therapeutics Inc. (MNLO): $1.35

0.03 (-2.17%)

POWR Rating

Component Grades

Momentum

NR

Stability

NR

Sentiment

Quality

NR

Add MNLO to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

NR

Ranked


in industry

MNLO Price/Volume Stats

Current price $1.35 52-week high $7.48
Prev. close $1.38 52-week low $1.00
Day low $1.30 Volume 1,561,200
Day high $1.39 Avg. volume 2,817,431
50-day MA $1.63 Dividend yield N/A
200-day MA $2.95 Market Cap 226.38M

MNLO Stock Price Chart Interactive Chart >


Menlo Therapeutics Inc. (MNLO) Company Bio


Menlo Therapeutics Inc., a biopharmaceutical company, focuses on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions in the United States. The company has completed Phase II clinical trials in pruritus associated with prurigo nodularis. It is also developing products that are in Phase II clinical trials in pruritus associated with psoriasis and atopic dermatitis, and refractory chronic cough. The company was formerly known as Tigercat Pharma, Inc. and changed its name to Menlo Therapeutics Inc. in May 2016. Menlo Therapeutics Inc. was founded in 2011 and is based in Redwood City, California.


MNLO Latest News Stream


Event/Time News Detail
Loading, please wait...

MNLO Latest Social Stream


Loading social stream, please wait...

View Full MNLO Social Stream

MNLO Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year -66.83%
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 0.00%
2019 12.62%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!